Get the Stockscreener App
3.93
0.51%
0.02
Pre-market:
3.93
Avita Medical Inc stock is traded at $3.93, with a volume of 242.83K.
It is up +0.51% in the last 24 hours and down -13.82% over the past month.
Avita is largely a single product company. Its RECELL system is an innovative burn treatment device which creates Spray-on Skin from a small skin sample within 30 minutes, thus avoiding or reducing the need for skin grafts. It's approved for the treatment of adult and paediatric patients in the US and an expanded indication for soft-tissue reconstruction. It is currently used in most of the 140 US burn centers. Despite having product approval in Australia, Canada, and China, Avita is not actively marketing in those territories and focussing instead on the US region, although international sales, particularly in Japan, are growing. Avita is domiciled, and has its primary listing, in the US.
See More
Previous Close:
$3.91
Open:
$3.95
24h Volume:
242.83K
Relative Volume:
1.02
Market Cap:
$120.95M
Revenue:
$72.35M
Net Income/Loss:
$-45.34M
P/E Ratio:
-2.5024
EPS:
-1.5705
Net Cash Flow:
$-32.43M
1W Performance:
-5.53%
1M Performance:
-13.82%
6M Performance:
+15.59%
1Y Performance:
-29.06%
1-Day Range:
$3.91
$4.12
1-Week Range:
$3.86
$4.25
52-Week Range:
$3.22
$7.12
Avita Medical Inc Stock (RCEL) Company Profile
Name
Avita Medical Inc
Sector
Industry
Phone
661-568-1317
Address
28159 AVENUE STANFORD, VALENCIA, CA
Compare RCEL vs ABT, SYK, MDT, BSX, EW
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
RCEL
Avita Medical Inc
|
3.93 | 120.95M | 72.35M | -45.34M | -32.43M | -1.5705 |
ABT
Abbott Laboratories
|
88.67 | 154.45B | 45.13B | 6.28B | 7.38B | 3.5895 |
SYK
Stryker Corp
|
307.94 | 118.05B | 25.27B | 3.34B | 4.57B | 8.6334 |
MDT
Medtronic Plc
|
80.38 | 103.20B | 36.36B | 4.84B | 5.43B | 3.7212 |
BSX
Boston Scientific Corp
|
46.76 | 69.50B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
86.28 | 49.68B | 6.30B | 1.07B | 1.09B | 1.8406 |
Avita Medical Inc Stock (RCEL) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Mar-05-26 | Initiated | Northland Capital | Outperform |
| Nov-20-25 | Upgrade | BTIG Research | Sell → Neutral |
| Aug-08-25 | Downgrade | BTIG Research | Neutral → Sell |
| Dec-24-24 | Initiated | D. Boral Capital | Buy |
| Apr-11-24 | Downgrade | BTIG Research | Buy → Neutral |
| Jun-27-23 | Initiated | Cantor Fitzgerald | Overweight |
| Mar-02-21 | Initiated | Piper Sandler | Overweight |
| Aug-27-20 | Initiated | BofA Securities | Buy |
| Apr-21-20 | Initiated | Oppenheimer | Outperform |
| Mar-03-20 | Initiated | BTIG Research | Buy |
View All
Avita Medical Inc Stock (RCEL) Latest News
AVITA Medical (RCEL) CFO receives 2,000-share equity grant in Form 4 - Stock Titan
Insider Buying: Joseph Woody Acquires Shares of AVITA Medical In - GuruFocus
Avita Medical director Woody Fralin buys $20,800 in common stock - Investing.com
AVITA Medical (RCEL) director adds 5,200 shares in open-market buy - Stock Titan
Avita Medical director Woody Fralin buys $20,800 in common stock By Investing.com - Investing.com Australia
Avita Medical director Woody Fralin buys $41,900 in stock By Investing.com - Investing.com India
Avita Medical director Woody Fralin buys $41,900 in stock - Investing.com
Insider Buying: Joseph Woody Acquires 10,000 Shares of AVITA Med - GuruFocus
Director Woody Fralin buys 10,000 AVITA Medical (RCEL) shares - Stock Titan
AVITA Medical, Inc. Issues Warrant Certificate to Perceptive Credit Holdings V, LP – Details, Terms, and Signatures - Minichart
AVITA Medical Issues Warrant to Perceptive Tied to $60 Million Credit Facility - TradingView
[8-K] AVITA Medical, Inc. Reports Material Event - Stock Titan
AVITA Medical (RCEL) registers 650,000 shares tied to Perceptive $3.40 warrant - Stock Titan
AVITA Medical (RCEL) director makes 10,000-share open-market stock purchase - Stock Titan
AVITA Medical Stock Is Moving: Shareholder Votes Put Cash, Warrants and Wound-Care Growth in Focus - Bez Kabli
AVITA MEDICAL INC (RCEL) Stock Chart - ChartMill
AVITA Medical (RCEL) director receives RSU and stock option awards - Stock Titan
AVITA Medical (NASDAQ: RCEL) grants RSUs and stock options to director - Stock Titan
AVITA Medical (RCEL) director Michael Tarnoff receives RSU and option grants - Stock Titan
AVITA Medical (RCEL) director receives RSU and option awards in equity grant - Stock Titan
AVITA Medical (RCEL) director Suzanne Crowe granted RSUs and stock options - Stock Titan
Director at AVITA Medical (NASDAQ: RCEL) granted RSUs and options - Stock Titan
Avita Medical, Inc. Ratifies Appointment of Grant Thornton LLP as Independent Registered Public Accounting Firm - marketscreener.com
Insider Buying: Joseph Woody Acquires 20,000 Shares of AVITA Med - GuruFocus
AVITA MEDICAL INC-2026 ASM BOARD CHAIR SCRIPT - Moomoo
AVITA Medical (NASDAQ: RCEL) investors approve director pay, warrants and extra equity capacity - Stock Titan
Director Woody Fralin buys 20,000 AVITA Medical (RCEL) shares - Stock Titan
AVITA Medical (RCEL) CFO acquires 5,000 shares through ESPP plan - Stock Titan
AVITA Medical (RCEL) CEO adds 5,000 shares through ESPP purchase - Stock Titan
Intention to Cease Coverage of Avita Medical - Morningstar
Intention to Cease Coverage of IDP Education, Polynovo, Avita, and Clinuvel - Morningstar
Avita Medical (RCEL) Stages a Notable Rebound, Testing Key Resistance ZoneALMA Signal - thelegaladvocate.com
RCEL Stock Price, Quote & Chart | AVITA MEDICAL INC (NASDAQ:RCEL) - ChartMill
Avita Medical Q1 2026 Earnings: EPS Misses Estimates as Strategic Investments ContinueRevenue Growth Report - thelegaladvocate.com
RCEL Q1 2026 Earnings: EPS Misses Estimates, Stock Gains Amid Operational ProgressPeak Earnings Alert - thelegaladvocate.com
Avita Medical (RCEL) Gains 2.2% as Shares Test Key Resistance at $4.81Composite Profile - Newser
Avita Medical Q1 earnings call highlights - MSN
Morgans says these ASX shares could rise 12% to 20% - MSN
Insider Buying: David O'Toole Acquires Shares of AVITA Medical I - GuruFocus
AVITA Medical (RCEL) CFO adds 2,000 shares in open-market buy - Stock Titan
AVITA Medical (RCEL) CFO adds 2,000 shares in open-market purchase - Stock Titan
AVITA Medical to Host Investor Webinar Briefing - The Manila Times
AVITA Medical to Host Investor Webinar Briefing | Associated Press | syndication news - Enidnews.com
Two AVITA Medical investor Q&As with CEO Cary Vance on May 20–21 - Stock Titan
AVITA Medical, Inc. (NASDAQ:RCEL) Q1 2026 Earnings Call Transcript - insidermonkey.com
AVITA Medical Q1 2026 earnings preview - MSN
RCEL Upgraded by Lake Street -- Price Target Raised to $6.00 - GuruFocus
Avita Medical Raised to Buy From Hold by Lake Street - Moomoo
Avita Medical, Inc. Stock 12‑Month Price Target Raised to $6.99, Implies 60% Upside - TradingView
Avita (RCEL) Q1 2026 Earnings Call Transcript - AOL.com
TD Cowen Maintains Avita Medical(RCEL.US) With Buy Rating, Maintains Target Price $5.5 - Moomoo
Avita Medical Inc Stock (RCEL) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.35%
0.87%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):